King Luther Capital Management Corp Reduces Holdings in Ralliant Corporation $RAL

King Luther Capital Management Corp trimmed its holdings in shares of Ralliant Corporation (NYSE:RAL) by 23.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,234 shares of the company’s stock after selling 14,721 shares during the period. King Luther Capital Management Corp’s holdings in Ralliant were worth $2,456,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the stock. Allworth Financial LP boosted its stake in shares of Ralliant by 134.4% during the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock valued at $26,000 after acquiring an additional 293 shares during the last quarter. Keybank National Association OH boosted its stake in shares of Ralliant by 1.6% during the fourth quarter. Keybank National Association OH now owns 19,667 shares of the company’s stock valued at $1,001,000 after acquiring an additional 305 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its stake in shares of Ralliant by 1.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 25,800 shares of the company’s stock valued at $1,313,000 after acquiring an additional 400 shares during the last quarter. Arizona State Retirement System boosted its stake in shares of Ralliant by 1.2% during the third quarter. Arizona State Retirement System now owns 33,566 shares of the company’s stock valued at $1,468,000 after acquiring an additional 413 shares during the last quarter. Finally, Danske Bank A S acquired a new stake in shares of Ralliant during the fourth quarter valued at $25,000.

Ralliant Price Performance

Shares of Ralliant stock opened at $62.37 on Friday. Ralliant Corporation has a twelve month low of $37.27 and a twelve month high of $62.95. The stock has a market capitalization of $6.98 billion and a P/E ratio of -5.70. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 0.73. The business’s fifty day moving average price is $48.41 and its 200 day moving average price is $48.59.

Ralliant (NYSE:RAL) last issued its earnings results on Tuesday, May 12th. The company reported $0.57 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.08. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.The firm had revenue of $534.60 million for the quarter. The company’s quarterly revenue was up 11.0% compared to the same quarter last year. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. As a group, research analysts anticipate that Ralliant Corporation will post 2.64 earnings per share for the current year.

Ralliant Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 23rd. Investors of record on Monday, June 8th will be issued a $0.05 dividend. The ex-dividend date is Monday, June 8th. This represents a $0.20 annualized dividend and a yield of 0.3%. Ralliant’s dividend payout ratio (DPR) is presently -1.83%.

Insider Transactions at Ralliant

In other Ralliant news, SVP Karen M. Bick sold 2,530 shares of the business’s stock in a transaction that occurred on Thursday, March 5th. The shares were sold at an average price of $46.50, for a total transaction of $117,645.00. Following the completion of the sale, the senior vice president directly owned 42,652 shares in the company, valued at $1,983,318. The trade was a 5.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Analysts Set New Price Targets

A number of research firms recently commented on RAL. Barclays increased their price objective on Ralliant from $52.00 to $67.00 and gave the company an “overweight” rating in a research note on Wednesday, May 13th. Truist Financial reissued a “buy” rating and set a $68.00 price objective (up from $53.00) on shares of Ralliant in a research note on Wednesday, May 13th. Oppenheimer upped their price objective on shares of Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Zacks Research raised shares of Ralliant from a “strong sell” rating to a “hold” rating in a research note on Monday, April 13th. Finally, Citigroup upped their price objective on shares of Ralliant from $51.00 to $70.00 and gave the company a “buy” rating in a research note on Wednesday, May 13th. Six research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $64.50.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.